Want to join the conversation?
$AIV expects 2Q16 EPS of $0.08-0.12, pro forma FFO per share of $0.54-0.58 and adjusted FFO per share of $0.45-0.49. $AIV's guidance for 2Q16 YoverY Same Store net operating income growth of 4% at the midpoint reflects a lower rate of growth than in 2Q15.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.